Skip to main content

Crystal Roger

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Crystal Roger as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

OPNT Opiant Pharmaceuticals, Inc.

Chief Executive Officer7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 31, 2023 (view filing)Jan 274 daysCrystal RogerChief Executive OfficerSSale−1.36K$20.26−$27.5K−1.8%75.3K after
Jan 9, 2023 (view filing)Jan 9Same dayCrystal RogerChief Executive OfficerSSale−1.18K$20.20−$23.9K−1.5%76.7K after
Jan 5, 2023 (view filing)Jan 5Same dayCrystal RogerChief Executive OfficerSSale−5.03K$20.20−$101.6K−6.1%77.9K after
Jul 15, 2022 (view filing)Jul 141 dayCrystal RogerChief Executive OfficerSSale−2.25K$11.11−$25.0K−2.6%82.9K after
Jan 27, 2022 (view filing)Jan 27Same dayCrystal RogerChief Executive OfficerSSale−2.00K$26.15−$52.2K−2.5%78.5K after
Jan 12, 2022 (view filing)Jan 102 daysCrystal RogerChief Executive OfficerSSale−1.06K$30.49−$32.3K−1.3%80.5K after
Sep 16, 2021 (view filing)Sep 16Same dayCrystal RogerChief Executive OfficerPPurchaseCommon Stock par value $0.001+100$23.44+$2.34K+2.0%5.10K after